We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
144 hedge funds and large institutions have $394M invested in Puma Biotechnology in 2019 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 55 increasing their positions, 28 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
96% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 28
17% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 30
3.95% more ownership
Funds ownership: 90.05% → 94% (+3.9%)
4% more funds holding
Funds holding: 139 → 144 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11% less capital invested
Capital invested by funds: $442M → $394M (-$48.4M)
18% less call options, than puts
Call options by funds: $6.45M | Put options by funds: $7.84M
Holders
144
Holders Change
+5
Holders Change %
+3.6%
% of All Funds
3.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
35
Increased
55
Reduced
28
Closed
30
Calls
$6.45M
Puts
$7.84M
Net Calls
-$1.39M
Net Calls Change
-$3.56M
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$19.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$7.22M |
| 3 |
SIM
Spark Investment Management
New York
|
-$3.34M |
| 4 |
Renaissance Technologies
New York
|
-$3.21M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.13M |
